Improved computational studies will give structural insights to development of new HCN modulators (activators and inhibitors), which may be useful for the treatment of several pathologies such as arrhythmias, Parkinson’s disease, and epilepsy [44,118,119,120,121,122,123]. This evidence concerns the gene MALAT1 and epilepsy.